Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that among patients with folliculitis decalvans, treatment with isotretinoin achieved the highest rate of stable remission compared to antibiotic regimens like clindamycin and rifampicin.

This case series reports 13 patients with folliculitis decalvans treated with antimicrobial therapy, highlighting the variability in response outcomes for this challenging condition.

This case report details a 37-year-old man who developed eosinophilic pustular dermatosis after previously resolving herpes zoster, with successful treatment using itraconazole and cycloproxolamine.

This case study describes a pregnant woman who developed a pruritic rash with follicular lesions containing yeast-like organisms, resistant to conventional acne treatments.

This report describes a case where a recalcitrant folliculitis decalvans was successfully treated with a long-pulsed Nd:YAG laser.

This case report describes a patient with folliculitis decalvans who successfully responded to photodynamic therapy.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Adalimumab improved folliculitis decalvans in most patients.

This case report describes an adult patient with tinea capitis due to Microsporum canis who experienced complete hair regrowth following treatment with fluconazole and ketoconazole shampoo.

In this retrospective study, oral isotretinoin monotherapy effectively achieved remission in 82% of patients with folliculitis decalvans, with those receiving ≥0.4 mg/kg/day for ≥3 months experiencing better outcomes and less frequent relapse.

This article reviews prominent variants of scalp hair folliculitis and their differential diagnosis, but reports no new clinical findings.

Chronic scalp inflammation can turn into cancer, so regular check-ups are important.

Topical dapsone gel reduced flare-ups in folliculitis decalvans without side effects.

In this report, a 26-year-old man with folliculitis decalvans unresponsive to standard treatments experienced significant disease clearance after 25 months of systemic photodynamic therapy, marking the first documented use of this therapy for this condition.

This case report describes a man with Touraine-Solente-Golé syndrome who achieved substantial improvement of tufted hair folliculitis after treatment with amoxicillin, clavulanic acid, and topical nadifloxacin.

Postoperative folliculitis after hair transplants is a minor issue that doesn't relate to patient details or how much hair is transplanted.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Tofacitinib may effectively treat folliculitis decalvans.

This article emphasizes the importance of educating dermatologists to reduce diagnostic delays in FD and highlights the need to screen for comorbid hidradenitis suppurativa and obtain bacterial cultures for effective treatment planning.

In this study, researchers reviewed cases of EGFR inhibitor-induced folliculitis decalvans and reported the first known occurrences associated with afatinib in three female NSCLC patients, highlighting the importance of early diagnosis and management to improve patient quality of life.

This case study suggests a possible rare follicular variant of neutrophilic dermatosis linked to myelogenous leukemia, where skin lesions improved following chemotherapy treatment.

This case study observed complete remission of folliculitis decalvans in a 24-year-old male after treatment with Ayurveda medicine and leech therapy, with sustained improvement over 33 months, suggesting potential effectiveness compared to other treatments.

This abstract describes the clinical characteristics of folliculitis, focusing on the presence of erythematous papules or pustules surrounding hair follicles.

The EADV Task Force on Hair Diseases reviewed existing literature and clinical experience to propose diagnostic and therapeutic recommendations for managing folliculitis decalvans, highlighting oral antibiotics, glucocorticosteroids, isotretinoin, and various systemic and topical therapies as key options for managing inflammation and preventing further hair loss.

This article suggests considering biologics to stabilize inflammation in moderate to severe folliculitis decalvans, although it reports no new clinical results.

This article discusses the characteristics and histopathology of folliculitis decalvans and reports no clinical results, highlighting the need for further research to understand its causes.

This study observed that an ointment containing pine turpentine oil, larch turpentine, and eucalyptus oil showed significant improvement over placebo in lesion evolution, responder rates, and patient assessments for treating acute folliculitis, while being well-tolerated across treatments.

In this case study, a female patient with folliculitis decalvans experienced hair re-growth and relief from symptoms like pain and burning after undergoing autologous fat transplantation, suggesting beneficial effects from stem cell therapy assisted by the inflammatory action of transplanted fat.

In this study, Deplanque et al. (2016) explored doxycycline's role in preventing erlotinib-induced folliculitis in patients with non-small-cell lung cancer, highlighting skin toxicity as a common side effect that can affect patient adherence to treatment.